日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease

HMB-002：一种单价抗体，可提高循环中VWF和FVIII水平，用于治疗血管性血友病。

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025018516
Häger, Mattias; Zivkovic, Minka; Gandhi, Prafull S; Rasmussen, Caroline; Bonvoisin, Cécile; Harrison, Rane A; Poulsen, Emil; Huskens, Dana; Roest, Mark; Ferrara, Fortunato; Naretto, Anais; Renaud, Lionel; Olsen, Ole H; Eskesen, Nicolas O; Holten-Andersen, Lars; Malladi, Ruthvik; Rea, Catherine J; Sørensen, Benny; Urbanus, Rolf T; Østergaard, Henrik
VWF
发表日期：2026
文献求助 收藏

Functional characterization of a nanobody-based glycoprotein VI-specific platelet agonist.

基于纳米抗体的糖蛋白VI特异性血小板激动剂的功能表征

期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2024.102582
Zivkovic Minka, Pols-van Veen Elisabeth, van der Vegte Vossa, Sebastian Silvie A E, de Moor Annick S, Korporaal Suzanne J A, Schutgens Roger E G, Urbanus Rolf T
其它
发表日期：2024
文献求助 收藏

Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti-β2-glycoprotein I antibody titers

狼疮抗凝物患者床旁国际标准化比值监测的干扰与抗β2糖蛋白I抗体滴度相关

期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2022.100011
Noordermeer, Tessa; Urbanus, Rolf T; Wong, Chong Y; Jansma, Janna J; Wiersma, Nynke M; Zivkovic, Minka; Huisman, Albert; Limper, Maarten
发表日期：2023
文献求助 收藏

Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery.

靶向丝氨酸蛋白酶抑制剂（TaSER）：一种双重作用的抗血栓药物，靶向血小板递送丝氨酸蛋白酶抑制剂

期刊:Journal of Thrombosis and Haemostasis
影响因子:5
doi:10.1111/jth.15554
Sanrattana Wariya, Smits Simone, Barendrecht Arjan D, van Kleef Nadine D, El Otmani Hinde, Zivkovic Minka, Roest Mark, Renné Thomas, Clark Chantal C, de Maat Steven, Maas Coen
其它
药物研究
发表日期：2022
文献求助 收藏